NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Man, I should have read that closer. I missed this:

Ongoing lung, ovarian, and prostate trials

You are talking about trials announced literally 24 years ago. 2 of which never ran. Prostate was officially withdrawn on clinicaltrials.gov. Lung never registered.
There was an ovarian P1 ran by U Pen, but the P2 was withdrawn in favor of alternate DC tech.

And you assert they are ongoing? Not even Dr Strange could track down your reality.

From 2001 SEC

DCVax. DCVax is a dendritic cell-based cancer immunotherapy platform. Our DCVax therapies are designed to safely elicit potent immune responses that eliminate cancer cells. We are currently developing four DCVax product candidates. Our lead DCVax product candidate, DCVax-Prostate, is a prostate
cancer treatment for which we are planning a Phase III clinical trial. We have observed stabilization of disease in 54% of the patients in our Phase I/II
clinical trial, and a PSMA-specific immune response to DCVax-Prostate in 75% of patients. To date, we have observed no significant adverse side effects from
DCVax-Prostate. Our second DCVax product candidate, DCVax-Brain, is moving towards a Phase II clinical trial for glioblastoma, a lethal form of brain
cancer. Our third DCVax product candidate, DCVax-Lung, is moving towards a Phase I clinical trial for non-small cell carcinoma, the most prevalent form of lung
cancer. Our fourth DCVax product candidate is designed to treat renal cancer and is in pre-clinical development.